STOCK TITAN

[Form 4] Bruker Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Bruker Corporation (BRKR) reported equity awards to Executive Vice President and CFO Gerald N. Herman on 08/15/2025 consisting of 25,844 Restricted Stock Units and 24,430 stock options with an exercise price of $36.872. Following the transactions Herman beneficially owns 102,583 shares and 24,430 options. Both the RSUs and the options vest in equal installments on each of the first four anniversaries of the original grant date, and the options become exercisable beginning 08/15/2026 with an expiration date of 08/15/2035. The transactions were reported on a Form 4 under Section 16.

Bruker Corporation (BRKR) ha comunicato il conferimento di premi azionari all'Executive Vice President e CFO Gerald N. Herman in data 15/08/2025: 25.844 Restricted Stock Units e 24.430 opzioni su azioni con prezzo di esercizio di $36,872. Dopo queste operazioni Herman detiene beneficiariamente 102.583 azioni e 24.430 opzioni. RSU e opzioni maturano in quote uguali in ciascuno dei primi quattro anniversari della data di assegnazione; le opzioni diventano esercitabili a partire dal 15/08/2026 e scadranno il 15/08/2035. Le operazioni sono state riportate su un Modulo 4 ai sensi della Sezione 16.

Bruker Corporation (BRKR) informó adjudicaciones de acciones al Vicepresidente Ejecutivo y CFO Gerald N. Herman el 15/08/2025, consistentes en 25.844 Restricted Stock Units y 24.430 opciones sobre acciones con un precio de ejercicio de $36,872. Tras las transacciones, Herman posee beneficiariamente 102.583 acciones y 24.430 opciones. Tanto las RSU como las opciones se consolidan en cuotas iguales en cada uno de los primeros cuatro aniversarios de la fecha de concesión; las opciones serán ejercitables desde el 15/08/2026 y vencerán el 15/08/2035. Las operaciones se informaron en un Formulario 4 conforme a la Sección 16.

Bruker Corporation (BRKR)는 2025년 08월 15일에 수석부사장이자 재무책임자(CFO) Gerald N. Herman에게 25,844 제한주식단위(Restricted Stock Units)와 행사가격 $36.87224,430 주식옵션을 교부했다고 보고했습니다. 이 거래 이후 Herman은 102,583주와 24,430옵션을 실질적으로 보유하게 됩니다. RSU와 옵션은 원래 부여일의 첫 4개 기념일 각각에 걸쳐 동일한 분할로 권리가 확정되며, 옵션은 2026년 08월 15일부터 행사 가능하고 만료일은 2035년 08월 15일입니다. 해당 거래는 섹션 16에 따라 Form 4에 보고되었습니다.

Bruker Corporation (BRKR) a déclaré des attributions de titres au Vice‑président exécutif et CFO Gerald N. Herman le 15/08/2025, consistant en 25 844 Restricted Stock Units et 24 430 options d'achat d'actions au prix d'exercice de $36,872. À la suite des opérations, Herman détient à titre bénéficiaire 102 583 actions et 24 430 options. Les RSU et les options acquièrent des droits par parts égales lors de chacun des quatre premiers anniversaires de la date d'attribution; les options sont exerçables à compter du 15/08/2026 et expirent le 15/08/2035. Les opérations ont été rapportées sur un Formulaire 4 en vertu de la Section 16.

Bruker Corporation (BRKR) meldete am 15.08.2025 Aktienzuteilungen an Executive Vice President und CFO Gerald N. Herman: 25.844 Restricted Stock Units und 24.430 Aktienoptionen mit einem Ausübungspreis von $36,872. Nach den Transaktionen besitzt Herman wirtschaftlich 102.583 Aktien und 24.430 Optionen. Sowohl die RSUs als auch die Optionen werden in gleichen Raten an den ersten vier Jahrestagen des ursprünglichen Gewährungsdatums unverfallbar; die Optionen werden ab dem 15.08.2026 ausübbar sein und verfallen am 15.08.2035. Die Vorgänge wurden gemäß Abschnitt 16 in einem Formular 4 gemeldet.

Positive
  • 25,844 Restricted Stock Units granted, which align executive incentives with shareholders
  • 24,430 stock options granted with a defined exercise price of $36.872
  • Vesting schedule in equal installments over four years promotes retention
  • Post-transaction beneficial ownership of 102,583 shares indicates meaningful insider stake
Negative
  • None.

Insights

TL;DR: Executive equity grants are routine compensation, modestly dilutive and align management with shareholder value.

The reported grants consist of 25,844 RSUs and 24,430 options at an exercise price of $36.872. Vesting over four years phases potential dilution and links compensation to retention and future performance. The option expiration in 2035 provides a long-term incentive window. This disclosure is standard for Section 16 officers and appears to be a compensation-related issuance rather than a sale or disposition.

TL;DR: Equity-based awards to a CFO are consistent with governance practices to align pay and performance.

The structure—RSUs plus time-vesting options—reflects common governance practice to promote retention and align interests with shareholders. Vesting in equal annual installments over four years creates multi-year service incentives. There is no indication in the filing of accelerated vesting or special terms beyond standard schedules. The disclosure meets Section 16 reporting requirements.

Bruker Corporation (BRKR) ha comunicato il conferimento di premi azionari all'Executive Vice President e CFO Gerald N. Herman in data 15/08/2025: 25.844 Restricted Stock Units e 24.430 opzioni su azioni con prezzo di esercizio di $36,872. Dopo queste operazioni Herman detiene beneficiariamente 102.583 azioni e 24.430 opzioni. RSU e opzioni maturano in quote uguali in ciascuno dei primi quattro anniversari della data di assegnazione; le opzioni diventano esercitabili a partire dal 15/08/2026 e scadranno il 15/08/2035. Le operazioni sono state riportate su un Modulo 4 ai sensi della Sezione 16.

Bruker Corporation (BRKR) informó adjudicaciones de acciones al Vicepresidente Ejecutivo y CFO Gerald N. Herman el 15/08/2025, consistentes en 25.844 Restricted Stock Units y 24.430 opciones sobre acciones con un precio de ejercicio de $36,872. Tras las transacciones, Herman posee beneficiariamente 102.583 acciones y 24.430 opciones. Tanto las RSU como las opciones se consolidan en cuotas iguales en cada uno de los primeros cuatro aniversarios de la fecha de concesión; las opciones serán ejercitables desde el 15/08/2026 y vencerán el 15/08/2035. Las operaciones se informaron en un Formulario 4 conforme a la Sección 16.

Bruker Corporation (BRKR)는 2025년 08월 15일에 수석부사장이자 재무책임자(CFO) Gerald N. Herman에게 25,844 제한주식단위(Restricted Stock Units)와 행사가격 $36.87224,430 주식옵션을 교부했다고 보고했습니다. 이 거래 이후 Herman은 102,583주와 24,430옵션을 실질적으로 보유하게 됩니다. RSU와 옵션은 원래 부여일의 첫 4개 기념일 각각에 걸쳐 동일한 분할로 권리가 확정되며, 옵션은 2026년 08월 15일부터 행사 가능하고 만료일은 2035년 08월 15일입니다. 해당 거래는 섹션 16에 따라 Form 4에 보고되었습니다.

Bruker Corporation (BRKR) a déclaré des attributions de titres au Vice‑président exécutif et CFO Gerald N. Herman le 15/08/2025, consistant en 25 844 Restricted Stock Units et 24 430 options d'achat d'actions au prix d'exercice de $36,872. À la suite des opérations, Herman détient à titre bénéficiaire 102 583 actions et 24 430 options. Les RSU et les options acquièrent des droits par parts égales lors de chacun des quatre premiers anniversaires de la date d'attribution; les options sont exerçables à compter du 15/08/2026 et expirent le 15/08/2035. Les opérations ont été rapportées sur un Formulaire 4 en vertu de la Section 16.

Bruker Corporation (BRKR) meldete am 15.08.2025 Aktienzuteilungen an Executive Vice President und CFO Gerald N. Herman: 25.844 Restricted Stock Units und 24.430 Aktienoptionen mit einem Ausübungspreis von $36,872. Nach den Transaktionen besitzt Herman wirtschaftlich 102.583 Aktien und 24.430 Optionen. Sowohl die RSUs als auch die Optionen werden in gleichen Raten an den ersten vier Jahrestagen des ursprünglichen Gewährungsdatums unverfallbar; die Optionen werden ab dem 15.08.2026 ausübbar sein und verfallen am 15.08.2035. Die Vorgänge wurden gemäß Abschnitt 16 in einem Formular 4 gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Herman Gerald N

(Last) (First) (Middle)
C/O BRUKER CORPORATION
40 MANNING ROAD

(Street)
BILLERICA MA 01821-3915

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EXECUTIVE VICE PRESIDENT, CFO
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 A 25,844(1) A $0 102,583 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Purchase) $36.872 08/15/2025 A 24,430 08/15/2026(2) 08/15/2035 Common Stock 24,430 $0 24,430 D
Explanation of Responses:
1. The Restricted Stock Units granted to the Reporting Person on August 15, 2025 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
2. The Stock Options granted to the Reporting Person on August 15, 2025 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
/s/ Michael Simone, Attorney-in-Fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did BRKR CFO Gerald N. Herman receive on 08/15/2025?

He received 25,844 Restricted Stock Units and 24,430 stock options with an exercise price of $36.872.

How do the RSUs and options vest for BRKR insider grants?

Both the RSUs and the stock options vest in equal installments on the first four anniversaries of the original grant date.

How many BRKR shares does the reporting person beneficially own after the transaction?

The Form 4 reports 102,583 shares beneficially owned following the reported transactions.

When do the options become exercisable and when do they expire?

The options are exercisable beginning 08/15/2026 and expire on 08/15/2035.

Does the Form 4 indicate any sale or disposition of shares by the reporting person?

No. The Form 4 reports acquisitions of RSUs and options (transaction code A), not dispositions.
Bruker Corp

NASDAQ:BRKR

BRKR Rankings

BRKR Latest News

BRKR Latest SEC Filings

BRKR Stock Data

5.19B
103.27M
31.91%
83.8%
6.15%
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA